secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioStem Technologies, Inc. (BSEM)
CIK:        0001658678
Form:       8-K
Filed at:   2026-09-30T20:48:24+00:00
Accession:  0001193125-26-409169
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

BioStem raises $3M private placement at $4.08/share; $10M BioTissue clearance payment due Sept 15 unpaid
--------------------------------------------------------------------------------

- Private placement of 735,296 shares at $4.08 plus Series A and Series B warrants for 735,296 shares each at $3.83; aggregate gross proceeds ~$3.0 million; closed September 30, 2026.
- Series A warrants expire five years and Series B warrants 24 months after effectiveness of the resale registration statement; full cash exercise would add roughly $5.6 million.
- H.C. Wainwright & Co. is exclusive placement agent, receiving a 7.0% cash fee plus 18,382 placement agent warrants exercisable at $6.12 per share.
- $10.0M Clearance Payment to BioTissue for Catalyze 510(k) clearance (received June 2026) was due Sept 15, 2026 and remains unpaid; company in talks on timing and terms.
- Resale registration statement due within 30 days, effectiveness targeted within 45 days (75 if SEC full review); warrants carry 4.99%/9.99% beneficial ownership blockers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658678/000119312526409169/0001193125-26-409169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658678/000119312526409169/bsem-20260929.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-409169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer